EFFECTS OF CIPROFLOXACIN AND ZINC CHLORIDE IN ADULT ALBINO RAT AND PRE-NATAL CONCEPTUS
AbstractBackground: Administration of quinolone therapy is controversial during growing age asstated by earlier authors. The flouroquinolones are currently not indicated for youngchildren because of arthropathy and adverse effect as new born shown by studies. Howeverthe effects of ciprofloxacin and ZnCl2 on prenatal conceptus have remained undocumented.The present study was designed to compare the effects on conceptus after maternalingestion of ciprofloxacin and ZnCl2 using Wastar albino rats. Methods: Ciprofloxacin andZnCl2 was administrated to pregnant female albino rats. Ciprofloxacin with a dose of 20mg/Kg bodyweight and ZnCl2 120 µg/100 gm bodyweight two times therapeutic dose for10 days (from day 8–18 of pregnancy). Each animal was weighted on day 1, day 8 and day18 of pregnancy. Abortion resulted on day 18th of pregnancy. Each group of pregnantanimals were sacrificed on day 18 of gestation by over dose of either anaesthesia, abdomenopened, uterus and both cornua containing conceptus identified, removed, there weightrecorded, crown rump length was measured and was compared with similar value of controlanimals. The results were statistically analysed to find out the significance. Results: Theciprofloxacin induces a mordanting effect as obviated by increased basophilia. Our studyreveals that ciprofloxacin administered in maternal, decreased maternal body weight to38.4±0.9 gm. However simultaneous ZnCl2 maintained the body weight to 41.4±0.7 gm,while ZnCl2 increased the body weight to 46.5±2.25 gm. The body weight and CrownRump length (CR Length) in conceptus decreased by 4.52±0.10 gm and 3.06±0.09 Cmrespectively. That ciprofloxacin and ZnCl2 administration maintained the body weight andCR length by 5.46±0.09 gm and 3.79±0.13 Cm respectively. That ZnCl2 administrationincreased the body weight and CR length by 6.71±0.05 gm and 4.15±0.08 Cm respectively.Conclusion: Prenatal administration of Ciprofloxacin caused reduction in growth rate andCR length, and ZnCl2 maintained body weight and CR length and growth of the ratconceptus.Keywords: Ciprofloxacin, ZnCl2, body weight, crown rump length, conceptus
Gangopadhyay Nibaren, Daniell Mark, Weigh LO Anna, Taylor
Heigh R. Fluoroquinlone and fortified antibiotics for treating
bacterial corneal ulcers. Br J Ophthalmol 2000;84(4):378–84.
Nelson JM, Chiller TM, Powers Jh, Angulo FJ. Fluoroquinoloneresistant compilobacter species and the withdrawal of
fluoroquinlones from use in poultry: a public health success story
Clin Infect Dis 2007;44(7);977–80.
Peterson LR, Lissack LM, Canter K, Fasching CE, Clabots C,
Gerding DN. Therapy of lower extremity infections with
ciprofloxacin in patient with diabetes mellitus, peripheral
vascular disease or both. Am J Med 1987;86:801–8.
Katzang BG. fluoroquinlones in: Basic & Clinical Pharmacology
th Ed. New york: Me Graw Hill 2007;p. 797–801.
Gillman GA, Hardman JG, Limbird LE. The quinolones. In:
Goodman & Gillman: The pharmacological basis of therapeutics.
th ed. New York. McGraw Hill 2007;11:1179–83.
Grassmick BK, Lehr VJ, Sundareson AS. Fulminant hepatic
failure possibly related to ciprofloxacin. Ann Pharmacother
Simpson J, Wasten AR, Mellersh A, Nelson CS, Dodd K.
Typhoid fever ciprofloxacin and renal failure. Arch Disc Child
Greenberg RN, Kennedy DJ, Reilly PM, Luppen KL. Treatment
of bones joint and soft tissue infections with oral ciprofloxacin
Anti Microb Agent Chemother 1987;31:151–5.
Hooper DC, Wolfsons Js, Swartz MN. Mechanism of action and
resistance to ciprofloxacin. Am J Med 1987;82(54):12–20.
Pfister K, Manzur D, Vormann J, Stahlmann R. Diminshed
ciprofloxacine-induced chondrotoxicity by suplimentation with
Magnecium and vitamin E in immature rats. Anti Microb Agent
and Chemother 2007;51(3)1022–7.
Arora NK. Are fluroquinolones safe in children? Indian J Pediatr:
Williams SB, Southern LL, Bidner TD. Effects of supplemental
dietary phytase and pharmacological concentrations of Zinc on
growth performance and tissue Zinc concentration of weanling
pigs. J Anim Sci 2005;83:386–92.
Rough R. Reproductive system in the mouse. 2nd ed,
Minneapolis; Burgess Pub Co. 1968; p. 269–99.
Lori EK, Slick KK. Experimental foetal alcohol syndrome
proposed pathogenic basis for a variety of associated facial and
brain anomalies. Am J Gen Med 1992;44:168–76.
Martindale W. The complete drug reference 33rd ed. Sweetman
SC London, Chicago Pharmaceutical Press 2002;182–5.
Bland M. Introductioin of medical statistics 1st ed. Oxford,
Oxford University Press 1987;p.165–87.
Drlica K, Zhao XK. DNA gyase, topoisomerase IV and 4-
quinolones. Microbiol Mol Biol Rev 1997;61(3):377–92.
Robinson MJ, Mortin BA, Gootz TD, McGuirk PR, Osheroff N.
Effects of Novel fluoroquinolones on the catalytic activities of
eukaryotic topoisomerase II: Influnce of the C-8 fluorine group.
Anti Microb Agent Chemother 1992;36(4):751–6.
Sissi C, Palumbo MC. The quinolone family: from antibacterial
to anticancer agents. Curr Med Chem Anticancer Agents
Dowd RO, Kent JC, Moseley JM, Wlodek ME. Effects of
uteroplacental insufficiency and reducing litter size on maternal
mammary function and post natal offspring growth. Am J Physiol
Mehlman CT, Methew E, Koeppling DO. Growth plate (physeal)
fractures: Treatment 2010. Available at:
WHO contributors. The impact of zinc supplemention on
childhood mortality and severe morbidity. World Health
Organization 2007. Available at: http:/www.who.int/childadolesecent-health/zinc-mortality.html.